These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 20927786)

  • 1. Salinosporamide natural products: Potent 20 S proteasome inhibitors as promising cancer chemotherapeutics.
    Gulder TA; Moore BS
    Angew Chem Int Ed Engl; 2010 Dec; 49(49):9346-67. PubMed ID: 20927786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterial self-resistance to the natural proteasome inhibitor salinosporamide A.
    Kale AJ; McGlinchey RP; Lechner A; Moore BS
    ACS Chem Biol; 2011 Nov; 6(11):1257-64. PubMed ID: 21882868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of salinosporamide A and its analogs as 20S proteasome inhibitors and SAR summarization.
    Ma Y; Qu L; Liu Z; Zhang L; Yang Z; Zhang L
    Curr Top Med Chem; 2011 Dec; 11(23):2906-22. PubMed ID: 21824108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antileukemic activity and mechanism of drug resistance to the marine Salinispora tropica proteasome inhibitor salinosporamide A (Marizomib).
    Niewerth D; Jansen G; Riethoff LF; van Meerloo J; Kale AJ; Moore BS; Assaraf YG; Anderl JL; Zweegman S; Kaspers GJ; Cloos J
    Mol Pharmacol; 2014 Jul; 86(1):12-9. PubMed ID: 24737138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salinosporamides D-J from the marine actinomycete Salinispora tropica, bromosalinosporamide, and thioester derivatives are potent inhibitors of the 20S proteasome.
    Reed KA; Manam RR; Mitchell SS; Xu J; Teisan S; Chao TH; Deyanat-Yazdi G; Neuteboom ST; Lam KS; Potts BC
    J Nat Prod; 2007 Feb; 70(2):269-76. PubMed ID: 17243724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Function-oriented biosynthesis of beta-lactone proteasome inhibitors in Salinispora tropica.
    Nett M; Gulder TA; Kale AJ; Hughes CC; Moore BS
    J Med Chem; 2009 Oct; 52(19):6163-7. PubMed ID: 19746976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic assembly of the salinosporamide γ-lactam-β-lactone anticancer warhead.
    Bauman KD; Shende VV; Chen PY; Trivella DBB; Gulder TAM; Vellalath S; Romo D; Moore BS
    Nat Chem Biol; 2022 May; 18(5):538-546. PubMed ID: 35314816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generating a generation of proteasome inhibitors: from microbial fermentation to total synthesis of salinosporamide a (marizomib) and other salinosporamides.
    Potts BC; Lam KS
    Mar Drugs; 2010 Mar; 8(4):835-80. PubMed ID: 20479958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiprotealide is a natural product.
    Manam RR; Macherla VR; Tsueng G; Dring CW; Weiss J; Neuteboom ST; Lam KS; Potts BC
    J Nat Prod; 2009 Feb; 72(2):295-7. PubMed ID: 19133779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A concise and straightforward total synthesis of (+/-)-salinosporamide A, based on a biosynthesis model.
    Mulholland NP; Pattenden G; Walters IA
    Org Biomol Chem; 2008 Aug; 6(15):2782-9. PubMed ID: 18633536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trypanocidal activity of β-lactone-γ-lactam proteasome inhibitors.
    Steverding D; Wang X; Potts BC; Palladino MA
    Planta Med; 2012 Jan; 78(2):131-4. PubMed ID: 22034066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biosynthetic convergence of salinosporamides A and B in the marine actinomycete Salinispora tropica.
    Beer LL; Moore BS
    Org Lett; 2007 Mar; 9(5):845-8. PubMed ID: 17274624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marine actinomycetes: a new source of compounds against the human malaria parasite.
    Prudhomme J; McDaniel E; Ponts N; Bertani S; Fenical W; Jensen P; Le Roch K
    PLoS One; 2008 Jun; 3(6):e2335. PubMed ID: 18523554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Marizomib, a potent second generation proteasome inhibitor from natural origin.
    Ma L; Diao A
    Anticancer Agents Med Chem; 2015; 15(3):298-306. PubMed ID: 25403165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutasynthesis of fluorosalinosporamide, a potent and reversible inhibitor of the proteasome.
    Eustáquio AS; Moore BS
    Angew Chem Int Ed Engl; 2008; 47(21):3936-8. PubMed ID: 18407559
    [No Abstract]   [Full Text] [Related]  

  • 16. Total synthesis of (-)-salinosporamide A.
    Satoh N; Yokoshima S; Fukuyama T
    Org Lett; 2011 Jun; 13(12):3028-31. PubMed ID: 21591679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand Based-Pharmacophore Modeling and Extended Bi oactivity Prediction for Salinosporamide A, B and C from Marine Actino mycetes Salinispora tropica.
    Dineshkumar K; Vasudevan A; Hopper W
    Comb Chem High Throughput Screen; 2017; 20(1):3-19. PubMed ID: 28000560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salinosporamide A (NPI-0052) potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through down-modulation of NF-kappaB regulated gene products.
    Ahn KS; Sethi G; Chao TH; Neuteboom ST; Chaturvedi MM; Palladino MA; Younes A; Aggarwal BB
    Blood; 2007 Oct; 110(7):2286-95. PubMed ID: 17609425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Total Synthesis of Salinosporamide A.
    Marx LB; Burton JW
    Chemistry; 2018 May; 24(26):6747-6754. PubMed ID: 29415322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total synthesis of lactacystin and salinosporamide A.
    Shibasaki M; Kanai M; Fukuda N
    Chem Asian J; 2007 Jan; 2(1):20-38. PubMed ID: 17441136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.